Stay updated on Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The revision tag was updated from v3.5.3 to v3.5.4, indicating a small maintenance update to the page's documentation/versioning. It does not change trial information or user-facing content.
    Difference
    0.1%
    Check dated 2026-05-14T23:17:09.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.3, replacing v3.5.2, indicating a new version of the page.
    Difference
    0.1%
    Check dated 2026-04-30T16:53:27.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T10:55:18.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Added the term Hepatocellular carcinoma and a new 'Genetic and Rare Diseases Information Center' resource; updated the site revision from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-18T18:02:32.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Page version updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:29:39.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The study now lists two locations, including Parkland Health & Hospital System in Dallas, TX; this augments the previously listed single-location site.
    Difference
    0.4%
    Check dated 2026-02-18T04:52:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Bavituximab in Advanced HCC Clinical Trial page.